Atlas Trials

A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple Sclerosis

Clinical trial NCT00004816 · COMPLETED

Trial details

NCT number
NCT00004816
Sponsor
National Center for Research Resources (NCRR)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
1995-07-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.